Con la colaboración de

Program

10:00-10:15

Welcome

10:15-11:50

Scientific Session I

Chairs: Roger Gomis (CIBERONC) & Manuel Tena (CIBEROBN)

10:15- 10:50

CIBERONC-OBN Talk

Joan Seoane (CIBERONC) & Miguel López (CIBEROBN): “Molecular Insights into Cancer Cachexia: Dissecting the Underlying Mechanisms”

10:50-11:15

CIBEROBN Talk

Estefanía Toledo Atucha (Miguel Ángel Martínez González) "Immuno-nutrition and cancer"

11:15- 11:50

CIBERONC-OBN Talk

Jesús Paramio (CIBERONC) & Raúl Luque (CIBEROBN): “Endocrine-related Cancers: Splicing makes the difference”

11:50 – 12:20 Coffee Break

12:20 – 13:55

Scientific Session II

Chairs: Natalia Martín (CIBERONC) & Guillermo Sánchez-Delgado (CIBEROBN)

12:20-12:45

CIBERONC Talk

Xosé Puente: "Effect of an oncogenic mutation in the splicing factor U1 on growth and metabolism"

12:45-13:10

CIBEROBN Talk

Francisco J Amaro-Gahete “Multidisciplinary prehabilitation and rehabilitation based on lifestyle changes for improving surgical prognosis in patients with colon cancer”

13:10-13:45

CIBERONC-OBN Talk

Silvia Guil-Luna (CIBERONC; IP: Antonio Rodriguez Ariza) y Dr. Hatim Boughanem (CIBEROBN; IP Francisco Tinahones) "Deterministic Epigenetic Reprogramming of Tumor-Associated Macrophages in Obesity and Cancer"

13:45-14:05

CIBERONC Talk

Xabier Agirre (Felipe Prosper Lab)” Transcriptional analyses of metabolic genes for identification of new targets and biomarkers in patients with hematological malignancies”

14:05 – 15:05 Lunch

15:05 – 16:35

Scientific Session III

Chairs: Irene Ferrer (CIBERONC) & Manuel Macías (CIBEROBN)

15:05-15:30

CIBEROBN Talk

Ana B Crujeiras (CIBEROBN) “Evaluation of Changes in the Methylome and Prognosis of Obesity-related Breast Cancer After Nutritional Intervention-induced Weight Loss During the Oncological Treatment: Study protocol and preliminary results"

15:30-15:55

CIBERONC Talk

Arkaitz Carracedo “Metabolic adaptations in prostate cancer”.

15:55-16:35

External Talk

Chair: Amaia Zabala (CIBERONC)

Patricia Altea-Manzano (CABIMER) “Emerging roles of lipid metabolism in cancer metastasis”.

16:35 – 17:00 - Break

17:00 – 18:00

Round Table - “Challenges and opportunities for Nutrition, Obesity and Cancer Metabolism Research”

Chair: Carlos Dieguez (CIBEROBN)

María Puy Portillo - Directora Científica CIBEROBN

Anna Bigas Salvans - Directora Científica CIBERONC

18:00 – 18:45

Plenary Talk - Integration of omics data into metabolic flux models: towards tumour metabolic stratification and the design of personalized therapies.

Laura Valle

Marta Cascante (CIBEREHD)

18:45 – 19:00

Closing remarks

8:00-9:00

Obesity + Nutrition meeting

Meeting restricted to Group Leaders and co-IP's

09:00-10:00

Nutrition Symposium (3 speakers; 15min + 5min discussion)

Chair: Jonatan R Ruiz

Building healthy bodies: Linking exercise, fat depots, and cardiometabolic risk and insulin resistance in children with overweight/obesity.

Cristina Cadenas-Sanchez. Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute (iMUDS), University of Granada, Granada. (PI: Jonatan Ruiz)

Nutritional determinants of metabolic health: new insights from precision nutrition approaches

Carmen Piernas. Dpt. Biochemistry and Molecular Biology II, Institute of Nutrition and Food Technology, Center for Biomedical Research (CIBM), University of Granada, Granada, Spain. Nuffield Department of Primary Care Health Sciences, Radcliffe Observatory Quarter, University of Oxford, Oxford, United Kingdom. (External CIBEROBN).

Ultraprocessed food consumption and obesity in children

Luis A Moreno. Instituto Agroalimentario de Aragón (IA2), Zaragoza, Spain. Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Zaragoza, Spain. (PI Luis A Moreno)

10:00-11:00

Oral presentations (5 speakers; 8min + 2min discussion)

Chair: Alfredo Martínez

Ultraprocessed Food Consumption and Cardiometabolic Risk Factors in Children From the CORALS Cohort

Nancy Elvira Babio Sánchez. Fundación Instituto de Investigación Sanitaria Pere Virgili, Universidad Rovira y Virgili, Spain. (PI Jordi Salas)

Time-restricted feeding prevents body weight gain, improves glucose tolerance and restores circulating corticosterone's circadian rhythm in males fed a high-fat high-sucrose diet

Maria del Mar Romero Romero. Facultad de Farmacia. Universidad de Barcelona, Spain. (PI Laura Herrero)

Adipocyte-specific deletion of Prdm1 confers resistance to diet-induced obesity and type 2 diabetes in mice.

María Jesús Moreno Aliaga. Centro de Investigación en Nutrición (CIN), Universidad de Navarra, Spain. (PI María Jesús Moreno Aliaga)

A role for brown adipose tissue activation in the prevention of hepatocarcinogenesis promoted by metabolic lipotoxicity.

Marta Giralt Facultad de Biologia, Universidad de Barcelona, Spain. (PI: Francesc Villarroya)

Sustainable insect-based protein supplement in the elderly: a pilot study.

Gemma Chiva-Blanch Fundación de Investigación Clínic Barcelona-Instituto de Investigaciones Biomédicas August Pi i Sunyer, Hospital Clínico y Provincial de Barcelona, Spain. (PI: Emilio Ortega).

11:00-11:30

Active coffee break + Group picture

11:30-12:30

Obesity Symposium (2 speakers; 15min + 5min discussion)

Chair: Concepción M Aguilera

Adiposity status, biomarkers and cancer risk.

Aurora Pérez Cornago European Commission, Joint Research Centre (JRC)), Ispra, Italy. (External CIBEROBN).

AI and machine learning for the holistic study of childhood obesity

Augusto Anguita Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain. (IP Mercedes Gil – Concepción M Aguilera).

12:30-13:15

Plenary talk (30 min + 10 min discussion)

Chair: Marijana Todorcevic

Human adipose tissue fat storage: a neglected target for metabolic health?.

Fredrick Karpe Oxford Centre for Diabetes, Endocrinology and Metabolism (OCDEM), Radcliffe Department of Medicine, University of Oxford, UK. (External CIBEROBN).

13:15-13:30

Best Oral Presentation Award

13:30-14:30

Acto de entrega del XXXI “Premio a la trayectoria científica Dr. Carles Martí Henneberg” del Instituto Danone España

Mesa institucional

• Presidiendo: María Puy, Directora Científica del CIBEROBN

• Copresidiendo: Dr. López Miranda, Presidente del Instituto Danone España y Jefe de Servicio de Medicina Interna del Hospital Universitario Reina Sofía.

• Padrino del galardonado: Dr. Leocadio Rodríguez Mañas, miembro del Comité Científico del Instituto Danone España y Jefe de Servicio de Geriatría del Hospital Universitario de Getafe.

• Galardonado: José M Fernández-Real, XXXI Galardonado con el “Premio a la trayectoria científica Dr. Carles Martí Henneberg” del Instituto Danone España. Department of Diabetes, Endocrinology and Nutrition, Dr Josep Trueta University Hospital, Girona, Spain; Nutrition, Eumetabolism and Health Group, Girona Biomedical Research Institute (IDIBGI-CERCA), Girona, Spain; CIBER Fisiopatología de la Obesidad y Nutrición (CIBERobn), Madrid, Spain.

Programa

• María del Puy Portillo, Directora Científica del CIBEROBN (5-7 minutos)

• José López Miranda, Presidente del Instituto Danone España (5-7 minutos)

• Leocadio Rodríguez Mañas, Padrino del galardonado (10-15 minutos)

• José M Fernández-Real. “Inflamación crónica y metabolismo: un viaje desde el tejido adiposo hasta el cerebro, con escala en la microbiota”. (20-25 minutos)

• Foto de familia (5 minutos)

14:30-15:30

Lunch

08:00 – 09:30

IP's meeting

Meeting restricted to Group Leaders and co-IP's

09:30 – 10:00

Welcome & CIBERONC session

Anna Bigas Salvans, CIBERONC Scientific Director

10:00 – 11:00

New groups in CIBERONC

10:00-10:20 – Iñaki Martin Subero

10:20-10:40 – Marcos Malumbres

10:40-10:50 – Pilar Garrido

10:50-11:00 – Clara Montagut

11:00-11:30

Coffee break

11:30 – 11:45

CIBERONC platforms

Conxi Lázaro: SPADA Hc: Spanish variant database for hereditary cance

11:45 – 14:15

Research programs

11:45 – 12:10

Tumors of the Respiratory Tract

Daniel González: “METACC: Leveraging ctDNA analysis to Identify Omic Biomarkers of Therapy Resistance in Metastatic Colorectal Cancer”

12:10 – 12:35

Breast and Gynecological Cancer

Aura Muntasell SMAD4 in Human NK Cells: Less Is More for Enhancing Adoptive NK Cell Therapy

12:35 – 13:00

Tumors of the Respiratory Tract

Francisco Hermida: “Genome-wide functional CRISPR screen reveals CDK7 as a targetable therapeutic vulnerability for head and neck cancer”

13:00 – 13:25

Hematological Tumors

Gerardo Ferrer Epigenetic Regulation of Therapy Responses in Hematological Malignancies

13:25 – 13:50

Cancer Molecular Mechanisms

Abel Gonzalez-Perez: “Five latent factors underlie response to immunotherapy”

13:50 – 14:15

Precision Diagnostic and Therapies

María Jesús VicentPolypeptide-based Nanomedicines: Unraveling Tropism and Overcoming Biological Barriers

14:15 – 14:30

Training and Mobility Program

Gema Moreno, Program Coordinator

14:30 – 15:30

Lunch